General Assembly Substitute Bill No. 970 seeks to amend the definitions and regulations surrounding cannabinoids, hemp, and hemp products in Connecticut, with a focus on clarifying the legal framework for these substances. The bill repeals and replaces subdivisions (29) to (62) of section 21a-240 of the general statutes, effective July 1, 2025. Key changes include redefining "Marijuana" to exclude certain low-THC hemp products and introducing new terms such as "moderate-THC hemp products" and "naturally manufactured hemp cannabinoids." The bill also removes references to high-THC hemp products from the definition of marijuana, thereby distinguishing between various cannabis products and aligning state law with evolving federal standards.

Additionally, the bill introduces new regulations for manufacturers regarding the disposal of non-compliant hemp products, mandates testing requirements for hemp intended for manufacturing, and establishes strict labeling requirements for hemp products. It emphasizes consumer protection by prohibiting health claims in advertising and ensuring that products display essential information such as THC content and expiration dates. The legislation also clarifies that THC in manufactured hemp products will not be classified as a controlled substance, allowing for greater flexibility in handling high-THC hemp products. Overall, the bill aims to modernize the regulatory framework for hemp in Connecticut, enhancing clarity, safety, and compliance with federal standards.